Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Migraine Treatment Market In 2029?
The market for migraine treatment has experienced robust growth in the recent past. The market is projected to expand from $3.18 billion in 2024 to $3.45 billion in 2025, with a compound annual growth rate (CAGR) of 8.4%. The historical period’s growth can be credited to factors like a higher incidence of migraines, a rise in healthcare spending, enhancements in the formulations of existing medications, the broadening scope of clinical research, and the emergence of new treatment methods.
Expectations are high for a swift expansion of the migraine treatment market in the upcoming years. Predictions indicate a growth to$5.21 billion in 2029, with a compound annual growth rate (CAGR) of 10.9%. This anticipated increase for the forecast period can be linked to heightened awareness and education, the introduction of monoclonal antibodies, increased attention on pediatric migraines, and the rise of non-pharmacological interventions. Crucial trends expected during this forecast period are improvements in therapeutic strategies, the advent of wearable tech and digital therapeutics, the emergence of telemedicine and remote consultation services, patient-focused care models, expansion in the generic drug market, and oral CGRP inhibitors.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8126&type=smp
Which Primay Drivers Are Accelerating Growth in the Migraine Treatment Market?
The extended duration of time spent on electronic screens is anticipated to drive the growth of the market for migraine treatments. When we refer to screen exposure, we mean the length of time that individuals dedicate to engaging with various electronic screens such as smartphones, tablets, computers, and television sets. Factors such as a rise in remote work, online learning, digital entertainment, and the increasing dependence on technology for social communication are fueling prolonged screen exposure. Treatments for migraines, which can include medication, changes in lifestyle, and ergonomic practices, aim to manage symptoms that are triggered or exacerbated by extended time on screens. For example, the House of Commons Committee, a health agency of the UK Parliament, reported in May 2024 that in 2021 screen time for children had risen by 52% and by 2022 nearly 25% of children and young individuals displayed smartphone usage habits indicative of behavioural addiction. Thus, extended screen exposure is spurring the expansion of the migraine treatment market.
Which Primary Segments of the Migraine Treatment Market Are Driving Growth and Industry Transformations?
The migraine treatmentmarket covered in this report is segmented –
1) By Types: Episodic; Migraine With Aura; Chronic; Other Types
2) By Treatment: Acute Or Abortive Treatment; Preventive Or prophylactic Treatment; Non-Pharmacological Therapies And Devices
3) By End-User: Hospitals; Clinics; Homecare; Other End-users
Subsegments:
1) By Episodic: Frequent Episodic Migraine; Infrequent Episodic Migraine
2) By Migraine With Aura: Visual Aura; Sensory Aura; Speech Or Language Aura
3) By Chronic: Chronic Migraine Without Aura; Chronic Migraine With Aura
4) By Other Types: Hemiplegic Migraine; Retinal Migraine; Menstrual Migraine; Other Specific Types
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=8126&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Migraine Treatment Market?# Market?
North America was the largest region in the migraine treatment market in 2024. The regions covered in the migraine treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Migraine Treatment Industry Dynamics?
The increasing popularity of product innovations is a notable trend in the migraine treatment market. Large enterprises in this sector are launching inventive products such as liquid formulas to maintain their competitive edge. For example, BioDelivery Sciences International (BDSI), a pharmaceutical company from the US, released Elyxyb (celecoxib oral solution) in January 2022. This product offers acute treatment for migraine in adults and is advantageous to those who experience aura. The quick absorption of its liquid formulation in the small intestine renders faster relief than conventional tablets. This is particularly useful for those who suffer from migraines accompanied by nausea or vomiting, as it negates the need for swallowing a pill and waiting for it to dissolve. Elyxyb, being the first FDA-approved oral solution for treating migraines ready to use, offers a more bearable and more effective option to manage the severe pain caused by migraines.
View the full report here:
https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report
What Parameters Are Used to Define the Migraine Treatment Market?
A migraine is a neurological condition, with the most prominent symptom being a throbbing, pulsating headache on one side of the brain. Migraine treatment is used to treat a headache that often affects one side of the head and can be extremely painful, throbbing, or pulsating by blocking the pathways in the brain that cause pain. With the help of migraine treatment, future attacks and migraine symptoms can be stopped.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8126
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model